Tweets
An early favorable response to TNFi initiation indicates better long-term success in RA. Assess early and adjust treatment accordingly.
#ACR24 @RheumNow ABST#2674 https://t.co/YTThYiiLpZ
Jiha Lee @JihaRheum ( View Tweet )
1 year 2 months ago
#ACR24 BEST Abstracts from Day 1
The RheumNow faculty have parked at the plenaries, trafficked the posters and have been finding the best the meeting offers on the first day.
https://t.co/FHu616Jpyq https://t.co/oKuRcGRRAZ
Dr. John Cush @RheumNow ( View Tweet )
1 year 2 months ago
Would you trust #AI to carry out & read your #USS?
2 systems, ARTHUR & DIANA, were comparable to that of a rheumatologist specialising in MSK US at joint & patient levels
Might this be the future of assessment in rheumatology care?
AbL20 #ACR24 @RheumNow https://t.co/XtnlYafzp4
Mrinalini Dey @DrMiniDey ( View Tweet )
1 year 2 months ago
Nailfold video capillaroscopy (NVC) allows the definite distinction between primary and secondary #Raynaud's phenomenon and can identify early changes such as few giant capillaries &/or microhemorrages
promoting early diagnosis
@RheumNow #ACR24 @rheumarhyme https://t.co/Yl37w6BEZR
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago
Another + #SLE #RCT - large N
#Dapirolizumab = Peg CD40L + SoC
Vs
#Placebo + SoC
Rapid improvemt
steroid sparing
So what to use in Pts if +Ph3
👇
TYK2 Deucravacitinib
JAKi Upadacitinib
Dapirolizumab
CAR 🚗 Rx
Anifrolimumab
Benlysta
ETC!
#ACRBest L16 @RheumNow #ACR24 https://t.co/wTFucF7BYO
Janet Pope @Janetbirdope ( View Tweet )
1 year 2 months ago
Late breaking abstract L17
CAR-NK Therapy for Refractory SLE.
In a trial of 20 severe SLE patients:
- 75% achieved LLDAS, 50% achieved DORIS remission at 6 months
- B cell reconstitution: 2–3 months post-treatment
- Safety: 2 mild cytokine release syndrome with fever; no severe… https://t.co/MS8cutm48o
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
The combe-like pattern is observed in pts with APS and also in overlap syndrome
- presence of parallel microthrombi (orange arrow) arranged perpendicularly, hence combe-like
@RheumNow #ACR24 @rheumarhyme https://t.co/IjX7ld9lxW
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago
The #scleroderma-like pattern on NVC is observed in pts with #dermatomyositis and MCTD
It consists of a combination of giant capillaries, some microhemorrhages, severe capillary loss and angiogenesis
@RheumNow #ACR24 @rheumarhyme https://t.co/WO9BOYn4ir
sheila @RHEUMarampa ( View Tweet )
1 year 2 months ago
In Vivo CAR T Cell Therapy.
A single intralymphatic injection of VivoVec™ particles:
- Generates functional CAR T cells in vivo
- Achieves complete B cell depletion in NHPs without lymphodepletion
- Demonstrates potential for an off-the-shelf solution for autoimmune disease… https://t.co/5DTzRvZjbY https://t.co/DvTOqnhn1V
Links:
Antoni Chan MD (Prof) @synovialjoints ( View Tweet )
1 year 2 months ago
Are weight loss drugs in #high #BMI
In
#Rheumatoid #arthritis
A #DMARD?
Yr in preview #ACR24 @RheumNow @ACRheum https://t.co/Hd1y0fFYxY
Links:
Janet Pope @Janetbirdope ( View Tweet )
1 year 2 months ago
Wt ⬇️ = Better #PROs in
👇autoimmune #rheumatic #diseases if > 5% wt loss.
#ACR24 @ACRheum @RheumNow
Didn’t work for non overwt
Ex Normal BMI and T2DM 🤷 https://t.co/81OuTfZ0Nx
Janet Pope @Janetbirdope ( View Tweet )
1 year 2 months ago
🚨 New SLE treatment update! 🚨 Dapirolizumab pegol (DZP), novel CD40L inhibitor, for moderate-to-severe lupus. Phase 3 trial, DZP reduced disease activity, helped taper steroids, and achieved a higher BICLA Safe and generally well tolerated! #ACR24 #L16 @rheumnow https://t.co/lFrKjz4CZ1
Bella Mehta @bella_mehta ( View Tweet )
1 year 2 months ago
